These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 23259607

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A semi-automated multiplex high-throughput assay for measuring IgG antibodies against Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) domains in small volumes of plasma.
    Cham GK, Kurtis J, Lusingu J, Theander TG, Jensen AT, Turner L.
    Malar J; 2008 Jun 12; 7():108. PubMed ID: 18549480
    [Abstract] [Full Text] [Related]

  • 4. Development of a high-throughput flexible quantitative suspension array assay for IgG against multiple Plasmodium falciparum antigens.
    Ubillos I, Campo JJ, Jiménez A, Dobaño C.
    Malar J; 2018 May 29; 17(1):216. PubMed ID: 29843713
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis of IgG responses to Plasmodium falciparum MSP1p19 and PF13-DBL1α1 using ELISA and a magnetic bead-based duplex assay (MAGPIX®-Luminex) in a Senegalese meso-endemic community.
    Perraut R, Richard V, Varela ML, Trape JF, Guillotte M, Tall A, Toure A, Sokhna C, Vigan-Womas I, Mercereau-Puijalon O.
    Malar J; 2014 Oct 17; 13():410. PubMed ID: 25326042
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multiple comparisons analysis of serological data from an area of low Plasmodium falciparum transmission.
    Rogier E, Wiegand R, Moss D, Priest J, Angov E, Dutta S, Journel I, Jean SE, Mace K, Chang M, Lemoine JF, Udhayakumar V, Barnwell JW.
    Malar J; 2015 Nov 04; 14():436. PubMed ID: 26537125
    [Abstract] [Full Text] [Related]

  • 8. Antibody Profiles to P. falciparum Antigens Over Time Characterize Acute and Long-Term Malaria Exposure in an Area of Low and Unstable Transmission.
    Ondigo BN, Hamre KES, Frosch AEP, Ayodo G, White MT, John CC.
    Am J Trop Med Hyg; 2020 Dec 04; 103(6):2189-2197. PubMed ID: 33124539
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1.
    Thomas AW, Trape JF, Rogier C, Goncalves A, Rosario VE, Narum DL.
    Am J Trop Med Hyg; 1994 Dec 04; 51(6):730-40. PubMed ID: 7810805
    [Abstract] [Full Text] [Related]

  • 12. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
    John CC, Moormann AM, Pregibon DC, Sumba PO, McHugh MM, Narum DL, Lanar DE, Schluchter MD, Kazura JW.
    Am J Trop Med Hyg; 2005 Jul 04; 73(1):222-8. PubMed ID: 16014863
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The establishment of a WHO Reference Reagent for anti-malaria (Plasmodium falciparum) human serum.
    Bryan D, Silva N, Rigsby P, Dougall T, Corran P, Bowyer PW, Ho MM, Collaborative study group.
    Malar J; 2017 Aug 05; 16(1):314. PubMed ID: 28779755
    [Abstract] [Full Text] [Related]

  • 16. Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum.
    Estévez PT, Satoguina J, Nwakanma DC, West S, Conway DJ, Drakeley CJ.
    Malar J; 2011 Apr 29; 10():104. PubMed ID: 21527045
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cerebral malaria is associated with IgG2 and IgG4 antibody responses to recombinant Plasmodium falciparum RIFIN antigen.
    Schreiber N, Brattig N, Evans J, Tsiri Agbenyega, Horstmann RD, May J, Klinkert MQ.
    Microbes Infect; 2006 Apr 29; 8(5):1269-76. PubMed ID: 16679041
    [Abstract] [Full Text] [Related]

  • 19. Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.
    Thera MA, Coulibaly D, Kone AK, Guindo AB, Traore K, Sall AH, Diarra I, Daou M, Traore IM, Tolo Y, Sissoko M, Niangaly A, Arama C, Baby M, Kouriba B, Sissoko MS, Sagara I, Toure OB, Dolo A, Diallo DA, Remarque E, Chilengi R, Noor R, Sesay S, Thomas A, Kocken CH, Faber BW, Imoukhuede EB, Leroy O, Doumbo OK.
    Malar J; 2016 Aug 30; 15(1):442. PubMed ID: 27577237
    [Abstract] [Full Text] [Related]

  • 20. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
    Adamou R, Dechavanne C, Sadissou I, d'Almeida T, Bouraima A, Sonon P, Amoussa R, Cottrell G, Le Port A, Theisen M, Remarque EJ, Longacre S, Moutairou K, Massougbodji A, Luty AJF, Nuel G, Migot-Nabias F, Sanni A, Garcia A, Milet J, Courtin D.
    Malar J; 2019 Jun 11; 18(1):194. PubMed ID: 31185998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.